A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis C
Clinical trial NCT01194037 · COMPLETED
Trial details
- NCT number
- NCT01194037
- Sponsor
- HanAll BioPharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-23
- Primary completion
- 2011-11-28
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.